Dr. Apter is attending ASCP Annual Meeting

🔷Starting May 29th, GCT President, Dr. Jeffrey Apter is attending ASCP Annual Meeting in Loews Hotel Miami. The event brings together regulatory specialists from FDA, EMA, NIMH, NIDA, NIAAA and industry key opinion leaders to discuss neuropsychiatric drug development.

🔷Dr. Apter has over 35 years of experience in CNS clinical trials as a PI and KOL. Do not loose a chance to link up with him in Miami or schedule a meeting in advance by contacting BD department!


GCT is a CRO experienced in performing clinical research in the USA, Europe, Russia and India.

We are a full-service clinical development provider, offering feasibility analysis, regulatory submission, site selection, project management, monitoring, data management, logistics, and more.

Go social with us

Follow us on social networks:

Privacy policy, Terms of service, Site map, Employees login



© 2001—2018 Global Clinical Trials, LLC

All rights reserved.